Kevin Feeley sold $486K of GeneDx (WGS)

Executed Mar 4, disclosed Mar 5, 1 day later.

Value, as filed

$486K

6,187 sh across 3 lots

Executed

Mar 4

the trade date, as filed

Disclosed

Mar 5

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Kevin Feeley CHIEF FINANCIAL OFFICER profile →

Kevin Feeley (CHIEF FINANCIAL OFFICER) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in GeneDx Holdings Corp. (WGS). The largest single filing was $526K of WGS (4,867 sh across 2 lots, as filed), executed Sep 30 2025.

The name

WGS

GeneDx Holdings Corp. WGS · Healthcare · 69 filings in 24 months ticker →

Healthcare · GeneDx Holdings Corp., a genomics company, provides genetic testing services

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Kevin Feeley in WGS

WGSSALE GeneDx Holdings Corp. $251K
2,549 sh across 2 lots
Exec Sep 16
Filed Sep 18 · 4:39 PM ET WGSSALE GeneDx Holdings Corp. $108K
1,285 sh × $84.22
Exec Sep 9
Filed Sep 11 · 4:10 PM ET WGSSALE GeneDx Holdings Corp. $128K
2,106 sh × $60.83
Exec Jun 16
Filed Jun 18 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. $433K
6,862 sh across 3 lots
Exec Mar 26
Filed Mar 30 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. $418K
5,449 sh across 2 lots
Exec Mar 16
Filed Mar 17 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. $111K
1,280 sh × $86.75
Exec Mar 9
Filed Mar 11 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. $237K
1,650 sh across 2 lots
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. $202K
1,266 sh × $159.28
Exec Dec 9 2025
Filed Dec 11 2025 · 5:30 PM ET